McKesson - MCK Stock Forecast, Price & News

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

McKesson Trading Up 2.1 %

McKesson stock opened at $354.77 on Wednesday. The company has a market cap of $50.99 billion, a P/E ratio of 37.50, a price-to-earnings-growth ratio of 1.43 and a beta of 0.63. McKesson has a 1-year low of $192.38 and a 1-year high of $358.64. The company has a fifty day simple moving average of $324.85 and a 200 day simple moving average of $307.94.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 3rd. Stockholders of record on Thursday, September 1st will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Wednesday, August 31st. This is an increase from McKesson's previous quarterly dividend of $0.47. McKesson's dividend payout ratio (DPR) is 19.87%.

Analyst Ratings Changes

Several equities research analysts have weighed in on MCK shares. UBS Group increased their target price on shares of McKesson from $380.00 to $400.00 and gave the stock a "buy" rating in a report on Thursday, August 4th. Mizuho increased their price objective on shares of McKesson from $331.00 to $345.00 and gave the stock a "neutral" rating in a research report on Thursday, August 4th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of McKesson from $378.00 to $409.00 in a research report on Monday. Morgan Stanley increased their price objective on shares of McKesson from $292.00 to $370.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 12th. Finally, Cowen increased their price objective on shares of McKesson from $325.00 to $361.00 and gave the stock an "outperform" rating in a research report on Monday, April 18th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $337.62.

Insider Activity

In other news, CEO Brian S. Tyler sold 8,678 shares of McKesson stock in a transaction dated Tuesday, May 17th. The shares were sold at an average price of $331.43, for a total value of $2,876,149.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Brian S. Tyler sold 8,678 shares of McKesson stock in a transaction dated Tuesday, May 17th. The shares were sold at an average price of $331.43, for a total value of $2,876,149.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Brian S. Tyler sold 1,535 shares of McKesson stock in a transaction dated Tuesday, June 21st. The shares were sold at an average price of $305.20, for a total transaction of $468,482.00. Following the completion of the transaction, the chief executive officer now directly owns 75,737 shares of the company's stock, valued at approximately $23,114,932.40. The disclosure for this sale can be found here. Insiders sold a total of 58,512 shares of company stock valued at $19,103,825 in the last quarter. Company insiders own 0.21% of the company's stock.